Company page
Antigenics Inc
Antigenics Inc, trading under the ticker ANTI, is a public company based in America with a market capitalization of $92 million. The company focuses on developing innovative solutions in the biotechnology sector. Antigenics aims to advance its research and product offerings to address unmet medical needs.
- Ticker
- ANTI:OTC
- Asset type
- Stock
- Market cap
- $92
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD